Thermo Fisher Scientific Inc. reports results for the quarter ended September 30 - Earnings Summary

Thermo Fisher Scientific

Yesterday 14:30

Thermo Fisher Scientific Inc. TMO.N reported quarterly adjusted earnings of $6.68​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $5.79.  The mean expectation of twenty three analysts for the quarter was for earnings of $6.40 per share. Wall Street expected results to range from $6.33  to $6.47 per share.
Revenue rose 9.1% to $12.14 billion from a year ago; analysts expected $11.95 billion. 
Thermo Fisher Scientific Inc.'s reported EPS for the quarter was $4.64​.
The company reported quarterly net income of $1.72 billion.
Thermo Fisher Scientific Inc. shares had risen by 1.8% this quarter and gained 18.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.6% in the last three months.​ 
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 27 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Thermo Fisher Scientific Inc. is $705.00, about 2.5% above its last closing price of $687.37
This summary was machine generated from LSEG data October 21 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Sep. 30 2026 
6.40
6.68
Beat
Jun. 30 2026 
5.71
6.03
Beat
Mar. 31 2026 
5.24
5.44
Beat
Dec. 31 2025 
6.45
6.57
Beat